FDA NDC Directory · JSON-LD · Markdown

Lacosamide

NDC 0121-2024 · HUMAN PRESCRIPTION DRUG · SOLUTION

Labeler / ManufacturerPAI Holdings, LLC dba PAI Pharma
Marketing categoryAbbreviated NDA (generic) · App ANDA216151
Dosage form / routeSOLUTION · ORAL
Active ingredientsLACOSAMIDE (100 mg/10mL)
Marketing started20220826
Package count1

External sources

Source: openFDA. Public-domain (CC0).